In vitro inhibition of Sclerotinia sclerotiorum mycelial growth and reduction of sclerotial viability by the volatile bioactive compounds of Brassicaceae crops
Date
2023-12
Type
Journal Article
Fields of Research
ANZSRC::300404 Crop and pasture biochemistry and physiology, ANZSRC::310202 Biological network analysis, ANZSRC::340403 Characterisation of biological macromolecules, ANZSRC::310803 Plant cell and molecular biology, ANZSRC::30 Agricultural, veterinary and food sciences, ANZSRC::31 Biological sciences, ANZSRC::32 Biomedical and clinical sciences
Abstract
Aims: Sclerotinia sclerotiorum is an important pathogen of a wide range of crops, with current control mostly relying on the use of fungicides. This study assessed the effect of biofumigation on in vitro inhibition of mycelial growth and reduction of sclerotial viability of S. sclerotiorum as an attempt to seek an alternative management strategy. Methods and results: The effect of different biofumigant crop types to inhibit mycelial growth of ten S. sclerotiorum isolates was investigated, with Brassica juncea 'Caliente 199' being the most effective biofumigant crop. The efficacy of 'Caliente 199' to inhibit mycelial growth and reduce sclerotial viability was influenced by different crop factors. Plant tissue of 'Caliente 199' harvested at 50% or 100% flowering and adjusted to 80% (w/w) moisture resulted in greater mycelial inhibition and a reduction in the sclerotial viability compared with the vegetative tissue with the same plant moisture. Mycelial inhibition and reduction of sclerotial viability were affected by tissue quantity. Whole plant tissue and shoots only resulted in a similar inhibition of mycelial growth, but whole plant tissue resulted in a greater reduction of sclerotial viability. The S. sclerotiorum isolates differed in sensitivity to the volatile bioactive compounds released by the biofumigant plant tissue.
Conclusions: The volatile bioactive compounds released by 'Caliente 199' resulted in effective mycelial inhibition but did not kill sclerotia completely.
Permalink
Source DOI
Rights
© The Author(s) 2023. Published by Oxford University Press on behalf of Applied Microbiology International.
Creative Commons Rights
Attribution